Davenport & Co’s Hims & Hers Health HIMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.78M Buy
+80,213
New +$2.15M 0.01% 497
2026
Q1
Sell
-71,689
Closed -$2.33M 1328
2025
Q4
$2.33M Sell
71,689
-508
-0.7% -$21.8K 0.01% 498
2025
Q3
$4.1M Buy
72,197
+704
+1% +$36.1K 0.02% 375
2025
Q2
$3.56M Sell
71,493
-135
-0.2% -$6.1K 0.02% 391
2025
Q1
$2.12M Buy
+71,628
New +$2.66M 0.01% 479

Other funds holding HIMS

Davenport & Co's HIMS Position: Q2 2026 in Review

Davenport & Co opened a new position in Hims & Hers Health (HIMS) in Q2 2026: 80,213 shares worth $2.78M. The stake represents 0.01% of the portfolio and ranks #497 among its holdings. This is a return to the name: Davenport & Co previously reported a position in HIMS as recently as Q4 2025.

Davenport & Co first reported a position in HIMS in Q1 2025 and has held it in 5 quarters since. The position peaked at $4.1M in Q3 2025. 506 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

  • Davenport & Co held 80,213 shares of Hims & Hers Health worth $2.78M as of Q2 2026.
  • Hims & Hers Health was a new Davenport & Co position in Q2 2026.
  • Hims & Hers Health made up 0.01% of Davenport & Co's portfolio in Q2 2026, its #497 holding.
  • Davenport & Co first reported a position in Hims & Hers Health in Q1 2025 and has held it in 5 quarters since.
  • Davenport & Co's Hims & Hers Health position peaked at $4.1M in Q3 2025.
  • 506 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on Davenport & Co's 13F filing for Q2 2026, filed 13 Jul 2026.